Deciphera Pharmaceuticals, Inc. (DCPH) has 128 open-market insider trades by 16 insiders since 2017. The most active filer is Thomas Patrick Kelly, CFO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Brightstar Associates LLC | 10% Owner | — | 2 | $44.8M | 2024-04-22 |
| Daniel Lee Flynn | CSO | — | 13 | $35.9M | 2023-06-16 |
| Michael Douglas Taylor | Dir | — | 23 | $35.6M | 2021-05-03 |
| New Leaf Venture Associates III, L.P. via Liam Ratcliffe | 10% Owner | — | 3 | $25.5M | 2019-08-16 |
| New Leaf Venture Management III, L.L.C. | 10% Owner | — | 1 | $12.7M | 2019-08-16 |
| James Arthur Bristol | Dir | — | 14 | $10.4M | 2021-04-20 |
| Thomas Patrick Kelly | CFO | — | 24 | $10.0M | 2024-02-16 |
| Liam Ratcliffe | Dir10% Owner | — | 1 | $6.4M | 2017-10-02 |
| Christopher John Morl | — | — | 6 | $5.1M | 2020-01-16 |
| Patricia L. Allen | Dir | — | 2 | $3.0M | 2020-06-05 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jama Pitman | SVP & Chief Development Officer | Sell | $35K | 2024-02-16 |
| Thomas Patrick Kelly | CFO | Sell | $47K | 2024-02-16 |
| Matthew L. Sherman | EVP & Chief Medical Officer | Sell | $41K | 2024-02-16 |
| Thomas Patrick Kelly | CFO | Sell | $35K | 2024-01-16 |
| Jama Pitman | SVP & Chief Development Officer | Sell | $23K | 2024-01-16 |
| Jama Pitman | — | Sell | $26K |
Companies that share insiders with DCPH, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-12-13 |
| Matthew L. Sherman | EVP & Chief Medical Officer | Sell | $43K | 2023-12-13 |
| Daniel C. Martin | Chief Commercial Officer | Sell | $27K | 2023-12-13 |
| Steven L. Hoerter | CEO & President | Sell | $943K | 2023-12-13 |
| Daniel C. Martin | CCO | Sell | $448K | 2023-11-30 |
| Thomas Patrick Kelly | CFO | Sell | $28K | 2023-10-30 |
| Matthew L. Sherman | EVP & Chief Medical Officer | Sell | $28K | 2023-10-30 |
| Jama Pitman | — | Sell | $17K | 2023-10-30 |
| Steven L. Hoerter | CEO & President | Sell | $519K | 2023-10-30 |
| Matthew L. Sherman | EVP & Chief Medical Officer | Sell | $37K | 2023-10-02 |